Increasing Incidence of Methicillin-Resistant Staphylococcus aureus in Hand Infections: A 3-Year County Hospital Experience

Background: Staphylococcus aureus is the most common cause of skin and soft-tissue infections. Methicillin-resistant S. aureus and community-acquired methicillin-resistant S. aureus have shown an increase in prevalence among soft-tissue infections over the past several years, with overall rates approaching 50 percent at the authors' institution in 2002. The object of this study was to determine the incidence of methicillin-resistant S. aureus with respect to hand infections, the antibiotic resistance pattern of methicillin-resistant S. aureus isolates, and implications for a change in antibiotic treatment algorithms for hand infections. Methods: A retrospective chart review of 761 patients with hand infections tracked by International Classification of Diseases, 9th Revision codes for finger or hand abscesses from 2001 to 2003 was performed at Parkland Memorial Hospital, Dallas, Texas. Culture results were obtained from 436 patients and analyzed for type of organism, and sensitivity profiles were obtained for all methicillin-resistant S. aureus isolates. Results: The median age of 761 patients was 40 years (range, 16 to 77 years); 71 percent were male and 28 percent were female. Of the 436 cultures reviewed, 371 (85 percent) had organisms identified. Methicillin-resistant S. aureus was the dominant single organism in hand infections cultured in all 3 years. The overall methicillin-resistant S. aureus rate was 61 percent of all hand infections in 2003. The percentage of S. aureus isolates identified as methicillin-resistant S. aureus increased from 55 percent to 78 percent over 3 years, up from 34 percent in 2001. Fortunately, 86 percent of these methicillin-resistant S. aureus isolates demonstrated sensitivity to conventional antibiotics, but a trend of resistance is developing. Conclusions: The incidence of community-acquired methicillin-resistant S. aureus increased from 34 percent to 61 percent over a 3-year period at the authors' county institution. An increasing trend of resistance patterns among conventional antibiotics was also demonstrated. As a result of this study, the treatment algorithm at Parkland Memorial Hospital has been modified to include abscess drainage accompanied by an antibiotic regimen targeted specifically at methicillin-resistant S. aureus. These data also have implications for broader application regarding simple skin infections and current antibiotic treatment algorithms.

[1]  E. Armstrong,et al.  Clinical and Economic Analysis of Methicillin-Susceptible and -Resistant Staphylococcus aureus Infections , 2004, The Annals of pharmacotherapy.

[2]  S. Iyer,et al.  Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak. , 2004, Journal of the American Academy of Dermatology.

[3]  B. Pollock,et al.  Methicillin-resistant Staphylococcus aureus infection in the Texas prison system. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Philip R. Cohen,et al.  Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem. , 2004, Journal of the American Academy of Dermatology.

[5]  A. Mejias,et al.  Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus , 2004, The Pediatric infectious disease journal.

[6]  Susan K. Johnson,et al.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. , 2003, JAMA.

[7]  M. Enright The evolution of a resistant pathogen--the case of MRSA. , 2003, Current opinion in pharmacology.

[8]  Ronald N. Jones,et al.  Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance Program , 2003, The Annals of pharmacotherapy.

[9]  J. Cove,et al.  Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections , 2003, Current opinion in infectious diseases.

[10]  S. Cosgrove,et al.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  R. Willke,et al.  Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial. , 2003, Surgical infections.

[12]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  S. Kaplan,et al.  Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children , 2002, The Pediatric infectious disease journal.

[14]  L. John,et al.  Linezolid versus Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections , 2002 .

[15]  J. Hunt,et al.  Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. Gaynes,et al.  Antimicrobial resistance in intensive care units. , 1999, Clinics in chest medicine.

[17]  B. Robinson-Dunn,et al.  Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. , 1999, The New England journal of medicine.

[18]  J. Carney,et al.  Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. , 1998, Archives of internal medicine.

[19]  D. Lauderdale,et al.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. , 1998, JAMA.

[20]  F. Moreno,et al.  Methicillin-resistant Staphylococcus aureus as a community organism. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  R. Levy,et al.  Treatment of cutaneous abscess: a double-blind clinical study. , 1985, Annals of emergency medicine.